nodes	percent_of_prediction	percent_of_DWPC	metapath
Tinidazole—CYP3A4—Bexarotene—hematologic cancer	0.054	0.0829	CbGbCtD
Tinidazole—CYP3A4—Lomustine—hematologic cancer	0.0502	0.0771	CbGbCtD
Tinidazole—CYP3A4—Busulfan—hematologic cancer	0.0502	0.0771	CbGbCtD
Tinidazole—CYP3A4—Thiotepa—hematologic cancer	0.0447	0.0687	CbGbCtD
Tinidazole—CYP3A4—Methoxsalen—hematologic cancer	0.0348	0.0534	CbGbCtD
Tinidazole—CYP3A4—Bortezomib—hematologic cancer	0.0331	0.0508	CbGbCtD
Tinidazole—CYP3A4—Daunorubicin—hematologic cancer	0.0316	0.0486	CbGbCtD
Tinidazole—CYP3A4—Cytarabine—hematologic cancer	0.0279	0.0429	CbGbCtD
Tinidazole—CYP3A4—Teniposide—hematologic cancer	0.0275	0.0422	CbGbCtD
Tinidazole—CYP3A4—Ifosfamide—hematologic cancer	0.0254	0.039	CbGbCtD
Tinidazole—CYP3A4—Imatinib—hematologic cancer	0.0242	0.0372	CbGbCtD
Tinidazole—CYP3A4—Ruxolitinib—hematologic cancer	0.0228	0.0351	CbGbCtD
Tinidazole—CYP3A4—Nilotinib—hematologic cancer	0.022	0.0338	CbGbCtD
Tinidazole—CYP3A4—Vinorelbine—hematologic cancer	0.0218	0.0335	CbGbCtD
Tinidazole—CYP3A4—Triamcinolone—hematologic cancer	0.02	0.0307	CbGbCtD
Tinidazole—CYP3A4—Dasatinib—hematologic cancer	0.0195	0.0299	CbGbCtD
Tinidazole—CYP3A4—Mitoxantrone—hematologic cancer	0.0192	0.0295	CbGbCtD
Tinidazole—CYP3A4—Betamethasone—hematologic cancer	0.0171	0.0263	CbGbCtD
Tinidazole—CYP3A4—Prednisolone—hematologic cancer	0.0169	0.026	CbGbCtD
Tinidazole—CYP3A4—Prednisone—hematologic cancer	0.016	0.0245	CbGbCtD
Tinidazole—CYP3A4—Irinotecan—hematologic cancer	0.0151	0.0233	CbGbCtD
Tinidazole—CYP3A4—Vinblastine—hematologic cancer	0.0135	0.0207	CbGbCtD
Tinidazole—CYP3A4—Vincristine—hematologic cancer	0.0132	0.0203	CbGbCtD
Tinidazole—CYP3A4—Etoposide—hematologic cancer	0.0121	0.0186	CbGbCtD
Tinidazole—CYP3A4—Dexamethasone—hematologic cancer	0.00997	0.0153	CbGbCtD
Tinidazole—CYP3A4—Doxorubicin—hematologic cancer	0.00827	0.0127	CbGbCtD
Tinidazole—Erythema multiforme—Epirubicin—hematologic cancer	6.67e-05	0.000191	CcSEcCtD
Tinidazole—Vomiting—Gemcitabine—hematologic cancer	6.65e-05	0.000191	CcSEcCtD
Tinidazole—Insomnia—Dexamethasone—hematologic cancer	6.65e-05	0.000191	CcSEcCtD
Tinidazole—Insomnia—Betamethasone—hematologic cancer	6.65e-05	0.000191	CcSEcCtD
Tinidazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	6.64e-05	0.00019	CcSEcCtD
Tinidazole—Paraesthesia—Dexamethasone—hematologic cancer	6.6e-05	0.000189	CcSEcCtD
Tinidazole—Paraesthesia—Betamethasone—hematologic cancer	6.6e-05	0.000189	CcSEcCtD
Tinidazole—Discomfort—Prednisone—hematologic cancer	6.6e-05	0.000189	CcSEcCtD
Tinidazole—Rash—Gemcitabine—hematologic cancer	6.6e-05	0.000189	CcSEcCtD
Tinidazole—Dermatitis—Gemcitabine—hematologic cancer	6.59e-05	0.000189	CcSEcCtD
Tinidazole—Hypersensitivity—Etoposide—hematologic cancer	6.58e-05	0.000189	CcSEcCtD
Tinidazole—Malnutrition—Methotrexate—hematologic cancer	6.56e-05	0.000188	CcSEcCtD
Tinidazole—Headache—Gemcitabine—hematologic cancer	6.56e-05	0.000188	CcSEcCtD
Tinidazole—Nausea—Vincristine—hematologic cancer	6.55e-05	0.000188	CcSEcCtD
Tinidazole—Flushing—Epirubicin—hematologic cancer	6.54e-05	0.000188	CcSEcCtD
Tinidazole—Hypersensitivity—Prednisolone—hematologic cancer	6.49e-05	0.000186	CcSEcCtD
Tinidazole—Hypoaesthesia—Doxorubicin—hematologic cancer	6.49e-05	0.000186	CcSEcCtD
Tinidazole—Pharyngitis—Doxorubicin—hematologic cancer	6.48e-05	0.000186	CcSEcCtD
Tinidazole—Dyspepsia—Dexamethasone—hematologic cancer	6.47e-05	0.000186	CcSEcCtD
Tinidazole—Dyspepsia—Betamethasone—hematologic cancer	6.47e-05	0.000186	CcSEcCtD
Tinidazole—Urinary tract disorder—Doxorubicin—hematologic cancer	6.44e-05	0.000185	CcSEcCtD
Tinidazole—Urticaria—Triamcinolone—hematologic cancer	6.44e-05	0.000185	CcSEcCtD
Tinidazole—Dysgeusia—Methotrexate—hematologic cancer	6.42e-05	0.000184	CcSEcCtD
Tinidazole—Asthenia—Etoposide—hematologic cancer	6.41e-05	0.000184	CcSEcCtD
Tinidazole—Body temperature increased—Triamcinolone—hematologic cancer	6.41e-05	0.000184	CcSEcCtD
Tinidazole—Angiopathy—Epirubicin—hematologic cancer	6.4e-05	0.000183	CcSEcCtD
Tinidazole—Urethral disorder—Doxorubicin—hematologic cancer	6.4e-05	0.000183	CcSEcCtD
Tinidazole—Decreased appetite—Betamethasone—hematologic cancer	6.39e-05	0.000183	CcSEcCtD
Tinidazole—Decreased appetite—Dexamethasone—hematologic cancer	6.39e-05	0.000183	CcSEcCtD
Tinidazole—Nausea—Irinotecan—hematologic cancer	6.38e-05	0.000183	CcSEcCtD
Tinidazole—Nausea—Mitoxantrone—hematologic cancer	6.38e-05	0.000183	CcSEcCtD
Tinidazole—Immune system disorder—Epirubicin—hematologic cancer	6.37e-05	0.000182	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Betamethasone—hematologic cancer	6.35e-05	0.000182	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Dexamethasone—hematologic cancer	6.35e-05	0.000182	CcSEcCtD
Tinidazole—Fatigue—Dexamethasone—hematologic cancer	6.34e-05	0.000182	CcSEcCtD
Tinidazole—Fatigue—Betamethasone—hematologic cancer	6.34e-05	0.000182	CcSEcCtD
Tinidazole—Pruritus—Etoposide—hematologic cancer	6.32e-05	0.000181	CcSEcCtD
Tinidazole—Nervous system disorder—Prednisone—hematologic cancer	6.28e-05	0.00018	CcSEcCtD
Tinidazole—Skin disorder—Prednisone—hematologic cancer	6.22e-05	0.000178	CcSEcCtD
Tinidazole—Nausea—Gemcitabine—hematologic cancer	6.22e-05	0.000178	CcSEcCtD
Tinidazole—Vomiting—Cisplatin—hematologic cancer	6.2e-05	0.000178	CcSEcCtD
Tinidazole—Hyperhidrosis—Prednisone—hematologic cancer	6.19e-05	0.000177	CcSEcCtD
Tinidazole—Erythema multiforme—Doxorubicin—hematologic cancer	6.17e-05	0.000177	CcSEcCtD
Tinidazole—Rash—Cisplatin—hematologic cancer	6.15e-05	0.000176	CcSEcCtD
Tinidazole—Dermatitis—Cisplatin—hematologic cancer	6.15e-05	0.000176	CcSEcCtD
Tinidazole—Malnutrition—Epirubicin—hematologic cancer	6.14e-05	0.000176	CcSEcCtD
Tinidazole—Diarrhoea—Etoposide—hematologic cancer	6.11e-05	0.000175	CcSEcCtD
Tinidazole—Anorexia—Prednisone—hematologic cancer	6.11e-05	0.000175	CcSEcCtD
Tinidazole—Ill-defined disorder—Methotrexate—hematologic cancer	6.09e-05	0.000174	CcSEcCtD
Tinidazole—Feeling abnormal—Dexamethasone—hematologic cancer	6.06e-05	0.000174	CcSEcCtD
Tinidazole—Feeling abnormal—Betamethasone—hematologic cancer	6.06e-05	0.000174	CcSEcCtD
Tinidazole—Flushing—Doxorubicin—hematologic cancer	6.06e-05	0.000174	CcSEcCtD
Tinidazole—Flatulence—Epirubicin—hematologic cancer	6.05e-05	0.000173	CcSEcCtD
Tinidazole—Gastrointestinal pain—Dexamethasone—hematologic cancer	6.01e-05	0.000172	CcSEcCtD
Tinidazole—Gastrointestinal pain—Betamethasone—hematologic cancer	6.01e-05	0.000172	CcSEcCtD
Tinidazole—Dysgeusia—Epirubicin—hematologic cancer	6.01e-05	0.000172	CcSEcCtD
Tinidazole—Hypersensitivity—Triamcinolone—hematologic cancer	5.97e-05	0.000171	CcSEcCtD
Tinidazole—Angiopathy—Doxorubicin—hematologic cancer	5.92e-05	0.00017	CcSEcCtD
Tinidazole—Malaise—Methotrexate—hematologic cancer	5.91e-05	0.000169	CcSEcCtD
Tinidazole—Dizziness—Etoposide—hematologic cancer	5.91e-05	0.000169	CcSEcCtD
Tinidazole—Muscle spasms—Epirubicin—hematologic cancer	5.9e-05	0.000169	CcSEcCtD
Tinidazole—Immune system disorder—Doxorubicin—hematologic cancer	5.89e-05	0.000169	CcSEcCtD
Tinidazole—Vertigo—Methotrexate—hematologic cancer	5.89e-05	0.000169	CcSEcCtD
Tinidazole—Leukopenia—Methotrexate—hematologic cancer	5.87e-05	0.000168	CcSEcCtD
Tinidazole—Urticaria—Dexamethasone—hematologic cancer	5.84e-05	0.000167	CcSEcCtD
Tinidazole—Urticaria—Betamethasone—hematologic cancer	5.84e-05	0.000167	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Prednisone—hematologic cancer	5.84e-05	0.000167	CcSEcCtD
Tinidazole—Dizziness—Prednisolone—hematologic cancer	5.83e-05	0.000167	CcSEcCtD
Tinidazole—Asthenia—Triamcinolone—hematologic cancer	5.82e-05	0.000167	CcSEcCtD
Tinidazole—Body temperature increased—Betamethasone—hematologic cancer	5.81e-05	0.000167	CcSEcCtD
Tinidazole—Body temperature increased—Dexamethasone—hematologic cancer	5.81e-05	0.000167	CcSEcCtD
Tinidazole—Abdominal pain—Dexamethasone—hematologic cancer	5.81e-05	0.000167	CcSEcCtD
Tinidazole—Abdominal pain—Betamethasone—hematologic cancer	5.81e-05	0.000167	CcSEcCtD
Tinidazole—Nausea—Cisplatin—hematologic cancer	5.79e-05	0.000166	CcSEcCtD
Tinidazole—Insomnia—Prednisone—hematologic cancer	5.79e-05	0.000166	CcSEcCtD
Tinidazole—Paraesthesia—Prednisone—hematologic cancer	5.75e-05	0.000165	CcSEcCtD
Tinidazole—Pruritus—Triamcinolone—hematologic cancer	5.74e-05	0.000164	CcSEcCtD
Tinidazole—Ill-defined disorder—Epirubicin—hematologic cancer	5.7e-05	0.000163	CcSEcCtD
Tinidazole—Convulsion—Methotrexate—hematologic cancer	5.68e-05	0.000163	CcSEcCtD
Tinidazole—Vomiting—Etoposide—hematologic cancer	5.68e-05	0.000163	CcSEcCtD
Tinidazole—Malnutrition—Doxorubicin—hematologic cancer	5.68e-05	0.000163	CcSEcCtD
Tinidazole—Dyspepsia—Prednisone—hematologic cancer	5.64e-05	0.000162	CcSEcCtD
Tinidazole—Rash—Etoposide—hematologic cancer	5.63e-05	0.000161	CcSEcCtD
Tinidazole—Dermatitis—Etoposide—hematologic cancer	5.63e-05	0.000161	CcSEcCtD
Tinidazole—Headache—Etoposide—hematologic cancer	5.6e-05	0.00016	CcSEcCtD
Tinidazole—Flatulence—Doxorubicin—hematologic cancer	5.6e-05	0.00016	CcSEcCtD
Tinidazole—Arthralgia—Methotrexate—hematologic cancer	5.58e-05	0.00016	CcSEcCtD
Tinidazole—Myalgia—Methotrexate—hematologic cancer	5.58e-05	0.00016	CcSEcCtD
Tinidazole—Decreased appetite—Prednisone—hematologic cancer	5.57e-05	0.00016	CcSEcCtD
Tinidazole—Dysgeusia—Doxorubicin—hematologic cancer	5.56e-05	0.000159	CcSEcCtD
Tinidazole—Rash—Prednisolone—hematologic cancer	5.56e-05	0.000159	CcSEcCtD
Tinidazole—Dermatitis—Prednisolone—hematologic cancer	5.55e-05	0.000159	CcSEcCtD
Tinidazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	5.55e-05	0.000159	CcSEcCtD
Tinidazole—Malaise—Epirubicin—hematologic cancer	5.54e-05	0.000159	CcSEcCtD
Tinidazole—Fatigue—Prednisone—hematologic cancer	5.52e-05	0.000158	CcSEcCtD
Tinidazole—Headache—Prednisolone—hematologic cancer	5.52e-05	0.000158	CcSEcCtD
Tinidazole—Discomfort—Methotrexate—hematologic cancer	5.52e-05	0.000158	CcSEcCtD
Tinidazole—Vertigo—Epirubicin—hematologic cancer	5.51e-05	0.000158	CcSEcCtD
Tinidazole—Leukopenia—Epirubicin—hematologic cancer	5.49e-05	0.000157	CcSEcCtD
Tinidazole—Constipation—Prednisone—hematologic cancer	5.48e-05	0.000157	CcSEcCtD
Tinidazole—Muscle spasms—Doxorubicin—hematologic cancer	5.46e-05	0.000156	CcSEcCtD
Tinidazole—Palpitations—Epirubicin—hematologic cancer	5.42e-05	0.000155	CcSEcCtD
Tinidazole—Confusional state—Methotrexate—hematologic cancer	5.4e-05	0.000155	CcSEcCtD
Tinidazole—Dizziness—Triamcinolone—hematologic cancer	5.36e-05	0.000154	CcSEcCtD
Tinidazole—Convulsion—Epirubicin—hematologic cancer	5.32e-05	0.000152	CcSEcCtD
Tinidazole—Nausea—Etoposide—hematologic cancer	5.31e-05	0.000152	CcSEcCtD
Tinidazole—Feeling abnormal—Prednisone—hematologic cancer	5.28e-05	0.000151	CcSEcCtD
Tinidazole—Asthenia—Betamethasone—hematologic cancer	5.28e-05	0.000151	CcSEcCtD
Tinidazole—Asthenia—Dexamethasone—hematologic cancer	5.28e-05	0.000151	CcSEcCtD
Tinidazole—Ill-defined disorder—Doxorubicin—hematologic cancer	5.27e-05	0.000151	CcSEcCtD
Tinidazole—Nervous system disorder—Methotrexate—hematologic cancer	5.25e-05	0.00015	CcSEcCtD
Tinidazole—Thrombocytopenia—Methotrexate—hematologic cancer	5.24e-05	0.00015	CcSEcCtD
Tinidazole—Gastrointestinal pain—Prednisone—hematologic cancer	5.24e-05	0.00015	CcSEcCtD
Tinidazole—Nausea—Prednisolone—hematologic cancer	5.24e-05	0.00015	CcSEcCtD
Tinidazole—Arthralgia—Epirubicin—hematologic cancer	5.23e-05	0.00015	CcSEcCtD
Tinidazole—Myalgia—Epirubicin—hematologic cancer	5.23e-05	0.00015	CcSEcCtD
Tinidazole—Pruritus—Betamethasone—hematologic cancer	5.2e-05	0.000149	CcSEcCtD
Tinidazole—Pruritus—Dexamethasone—hematologic cancer	5.2e-05	0.000149	CcSEcCtD
Tinidazole—Skin disorder—Methotrexate—hematologic cancer	5.2e-05	0.000149	CcSEcCtD
Tinidazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	5.19e-05	0.000149	CcSEcCtD
Tinidazole—Hyperhidrosis—Methotrexate—hematologic cancer	5.17e-05	0.000148	CcSEcCtD
Tinidazole—Discomfort—Epirubicin—hematologic cancer	5.16e-05	0.000148	CcSEcCtD
Tinidazole—Vomiting—Triamcinolone—hematologic cancer	5.15e-05	0.000148	CcSEcCtD
Tinidazole—Malaise—Doxorubicin—hematologic cancer	5.12e-05	0.000147	CcSEcCtD
Tinidazole—Rash—Triamcinolone—hematologic cancer	5.11e-05	0.000146	CcSEcCtD
Tinidazole—Dermatitis—Triamcinolone—hematologic cancer	5.11e-05	0.000146	CcSEcCtD
Tinidazole—Vertigo—Doxorubicin—hematologic cancer	5.1e-05	0.000146	CcSEcCtD
Tinidazole—Anorexia—Methotrexate—hematologic cancer	5.1e-05	0.000146	CcSEcCtD
Tinidazole—Urticaria—Prednisone—hematologic cancer	5.09e-05	0.000146	CcSEcCtD
Tinidazole—Leukopenia—Doxorubicin—hematologic cancer	5.08e-05	0.000146	CcSEcCtD
Tinidazole—Headache—Triamcinolone—hematologic cancer	5.08e-05	0.000146	CcSEcCtD
Tinidazole—Abdominal pain—Prednisone—hematologic cancer	5.06e-05	0.000145	CcSEcCtD
Tinidazole—Body temperature increased—Prednisone—hematologic cancer	5.06e-05	0.000145	CcSEcCtD
Tinidazole—Confusional state—Epirubicin—hematologic cancer	5.05e-05	0.000145	CcSEcCtD
Tinidazole—Diarrhoea—Dexamethasone—hematologic cancer	5.03e-05	0.000144	CcSEcCtD
Tinidazole—Diarrhoea—Betamethasone—hematologic cancer	5.03e-05	0.000144	CcSEcCtD
Tinidazole—Palpitations—Doxorubicin—hematologic cancer	5.02e-05	0.000144	CcSEcCtD
Tinidazole—Convulsion—Doxorubicin—hematologic cancer	4.92e-05	0.000141	CcSEcCtD
Tinidazole—Nervous system disorder—Epirubicin—hematologic cancer	4.91e-05	0.000141	CcSEcCtD
Tinidazole—Thrombocytopenia—Epirubicin—hematologic cancer	4.9e-05	0.000141	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Methotrexate—hematologic cancer	4.88e-05	0.00014	CcSEcCtD
Tinidazole—Skin disorder—Epirubicin—hematologic cancer	4.87e-05	0.000139	CcSEcCtD
Tinidazole—Dizziness—Dexamethasone—hematologic cancer	4.86e-05	0.000139	CcSEcCtD
Tinidazole—Dizziness—Betamethasone—hematologic cancer	4.86e-05	0.000139	CcSEcCtD
Tinidazole—Hyperhidrosis—Epirubicin—hematologic cancer	4.84e-05	0.000139	CcSEcCtD
Tinidazole—Insomnia—Methotrexate—hematologic cancer	4.84e-05	0.000139	CcSEcCtD
Tinidazole—Myalgia—Doxorubicin—hematologic cancer	4.84e-05	0.000139	CcSEcCtD
Tinidazole—Arthralgia—Doxorubicin—hematologic cancer	4.84e-05	0.000139	CcSEcCtD
Tinidazole—Nausea—Triamcinolone—hematologic cancer	4.81e-05	0.000138	CcSEcCtD
Tinidazole—Paraesthesia—Methotrexate—hematologic cancer	4.81e-05	0.000138	CcSEcCtD
Tinidazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	4.8e-05	0.000138	CcSEcCtD
Tinidazole—Discomfort—Doxorubicin—hematologic cancer	4.78e-05	0.000137	CcSEcCtD
Tinidazole—Anorexia—Epirubicin—hematologic cancer	4.78e-05	0.000137	CcSEcCtD
Tinidazole—Dyspnoea—Methotrexate—hematologic cancer	4.77e-05	0.000137	CcSEcCtD
Tinidazole—Somnolence—Methotrexate—hematologic cancer	4.76e-05	0.000136	CcSEcCtD
Tinidazole—Hypersensitivity—Prednisone—hematologic cancer	4.72e-05	0.000135	CcSEcCtD
Tinidazole—Dyspepsia—Methotrexate—hematologic cancer	4.71e-05	0.000135	CcSEcCtD
Tinidazole—Vomiting—Betamethasone—hematologic cancer	4.68e-05	0.000134	CcSEcCtD
Tinidazole—Vomiting—Dexamethasone—hematologic cancer	4.68e-05	0.000134	CcSEcCtD
Tinidazole—Confusional state—Doxorubicin—hematologic cancer	4.67e-05	0.000134	CcSEcCtD
Tinidazole—Decreased appetite—Methotrexate—hematologic cancer	4.65e-05	0.000133	CcSEcCtD
Tinidazole—Rash—Betamethasone—hematologic cancer	4.64e-05	0.000133	CcSEcCtD
Tinidazole—Rash—Dexamethasone—hematologic cancer	4.64e-05	0.000133	CcSEcCtD
Tinidazole—Dermatitis—Betamethasone—hematologic cancer	4.63e-05	0.000133	CcSEcCtD
Tinidazole—Dermatitis—Dexamethasone—hematologic cancer	4.63e-05	0.000133	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Methotrexate—hematologic cancer	4.62e-05	0.000132	CcSEcCtD
Tinidazole—Fatigue—Methotrexate—hematologic cancer	4.62e-05	0.000132	CcSEcCtD
Tinidazole—Headache—Betamethasone—hematologic cancer	4.61e-05	0.000132	CcSEcCtD
Tinidazole—Headache—Dexamethasone—hematologic cancer	4.61e-05	0.000132	CcSEcCtD
Tinidazole—Asthenia—Prednisone—hematologic cancer	4.6e-05	0.000132	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Epirubicin—hematologic cancer	4.56e-05	0.000131	CcSEcCtD
Tinidazole—Nervous system disorder—Doxorubicin—hematologic cancer	4.55e-05	0.00013	CcSEcCtD
Tinidazole—Thrombocytopenia—Doxorubicin—hematologic cancer	4.54e-05	0.00013	CcSEcCtD
Tinidazole—Pruritus—Prednisone—hematologic cancer	4.53e-05	0.00013	CcSEcCtD
Tinidazole—Insomnia—Epirubicin—hematologic cancer	4.53e-05	0.00013	CcSEcCtD
Tinidazole—Skin disorder—Doxorubicin—hematologic cancer	4.5e-05	0.000129	CcSEcCtD
Tinidazole—Paraesthesia—Epirubicin—hematologic cancer	4.5e-05	0.000129	CcSEcCtD
Tinidazole—Hyperhidrosis—Doxorubicin—hematologic cancer	4.48e-05	0.000128	CcSEcCtD
Tinidazole—Dyspnoea—Epirubicin—hematologic cancer	4.47e-05	0.000128	CcSEcCtD
Tinidazole—Somnolence—Epirubicin—hematologic cancer	4.45e-05	0.000128	CcSEcCtD
Tinidazole—Anorexia—Doxorubicin—hematologic cancer	4.42e-05	0.000127	CcSEcCtD
Tinidazole—Feeling abnormal—Methotrexate—hematologic cancer	4.41e-05	0.000126	CcSEcCtD
Tinidazole—Dyspepsia—Epirubicin—hematologic cancer	4.41e-05	0.000126	CcSEcCtD
Tinidazole—Diarrhoea—Prednisone—hematologic cancer	4.38e-05	0.000126	CcSEcCtD
Tinidazole—Gastrointestinal pain—Methotrexate—hematologic cancer	4.38e-05	0.000125	CcSEcCtD
Tinidazole—Nausea—Betamethasone—hematologic cancer	4.37e-05	0.000125	CcSEcCtD
Tinidazole—Nausea—Dexamethasone—hematologic cancer	4.37e-05	0.000125	CcSEcCtD
Tinidazole—Decreased appetite—Epirubicin—hematologic cancer	4.35e-05	0.000125	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Epirubicin—hematologic cancer	4.32e-05	0.000124	CcSEcCtD
Tinidazole—Fatigue—Epirubicin—hematologic cancer	4.32e-05	0.000124	CcSEcCtD
Tinidazole—Constipation—Epirubicin—hematologic cancer	4.28e-05	0.000123	CcSEcCtD
Tinidazole—Urticaria—Methotrexate—hematologic cancer	4.25e-05	0.000122	CcSEcCtD
Tinidazole—Dizziness—Prednisone—hematologic cancer	4.24e-05	0.000121	CcSEcCtD
Tinidazole—Body temperature increased—Methotrexate—hematologic cancer	4.23e-05	0.000121	CcSEcCtD
Tinidazole—Abdominal pain—Methotrexate—hematologic cancer	4.23e-05	0.000121	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	4.22e-05	0.000121	CcSEcCtD
Tinidazole—Insomnia—Doxorubicin—hematologic cancer	4.19e-05	0.00012	CcSEcCtD
Tinidazole—Paraesthesia—Doxorubicin—hematologic cancer	4.16e-05	0.000119	CcSEcCtD
Tinidazole—Dyspnoea—Doxorubicin—hematologic cancer	4.13e-05	0.000118	CcSEcCtD
Tinidazole—Feeling abnormal—Epirubicin—hematologic cancer	4.13e-05	0.000118	CcSEcCtD
Tinidazole—Somnolence—Doxorubicin—hematologic cancer	4.12e-05	0.000118	CcSEcCtD
Tinidazole—Gastrointestinal pain—Epirubicin—hematologic cancer	4.1e-05	0.000117	CcSEcCtD
Tinidazole—Dyspepsia—Doxorubicin—hematologic cancer	4.08e-05	0.000117	CcSEcCtD
Tinidazole—Vomiting—Prednisone—hematologic cancer	4.07e-05	0.000117	CcSEcCtD
Tinidazole—Rash—Prednisone—hematologic cancer	4.04e-05	0.000116	CcSEcCtD
Tinidazole—Dermatitis—Prednisone—hematologic cancer	4.03e-05	0.000116	CcSEcCtD
Tinidazole—Decreased appetite—Doxorubicin—hematologic cancer	4.03e-05	0.000115	CcSEcCtD
Tinidazole—Headache—Prednisone—hematologic cancer	4.01e-05	0.000115	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Doxorubicin—hematologic cancer	4e-05	0.000115	CcSEcCtD
Tinidazole—Fatigue—Doxorubicin—hematologic cancer	4e-05	0.000115	CcSEcCtD
Tinidazole—Urticaria—Epirubicin—hematologic cancer	3.98e-05	0.000114	CcSEcCtD
Tinidazole—Constipation—Doxorubicin—hematologic cancer	3.96e-05	0.000114	CcSEcCtD
Tinidazole—Body temperature increased—Epirubicin—hematologic cancer	3.96e-05	0.000113	CcSEcCtD
Tinidazole—Abdominal pain—Epirubicin—hematologic cancer	3.96e-05	0.000113	CcSEcCtD
Tinidazole—Hypersensitivity—Methotrexate—hematologic cancer	3.94e-05	0.000113	CcSEcCtD
Tinidazole—Asthenia—Methotrexate—hematologic cancer	3.84e-05	0.00011	CcSEcCtD
Tinidazole—Feeling abnormal—Doxorubicin—hematologic cancer	3.82e-05	0.000109	CcSEcCtD
Tinidazole—Nausea—Prednisone—hematologic cancer	3.8e-05	0.000109	CcSEcCtD
Tinidazole—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.79e-05	0.000109	CcSEcCtD
Tinidazole—Pruritus—Methotrexate—hematologic cancer	3.79e-05	0.000109	CcSEcCtD
Tinidazole—Hypersensitivity—Epirubicin—hematologic cancer	3.69e-05	0.000106	CcSEcCtD
Tinidazole—Urticaria—Doxorubicin—hematologic cancer	3.68e-05	0.000106	CcSEcCtD
Tinidazole—Abdominal pain—Doxorubicin—hematologic cancer	3.66e-05	0.000105	CcSEcCtD
Tinidazole—Body temperature increased—Doxorubicin—hematologic cancer	3.66e-05	0.000105	CcSEcCtD
Tinidazole—Diarrhoea—Methotrexate—hematologic cancer	3.66e-05	0.000105	CcSEcCtD
Tinidazole—Asthenia—Epirubicin—hematologic cancer	3.59e-05	0.000103	CcSEcCtD
Tinidazole—Pruritus—Epirubicin—hematologic cancer	3.54e-05	0.000102	CcSEcCtD
Tinidazole—Dizziness—Methotrexate—hematologic cancer	3.54e-05	0.000101	CcSEcCtD
Tinidazole—Diarrhoea—Epirubicin—hematologic cancer	3.43e-05	9.82e-05	CcSEcCtD
Tinidazole—Hypersensitivity—Doxorubicin—hematologic cancer	3.42e-05	9.79e-05	CcSEcCtD
Tinidazole—Vomiting—Methotrexate—hematologic cancer	3.4e-05	9.75e-05	CcSEcCtD
Tinidazole—Rash—Methotrexate—hematologic cancer	3.38e-05	9.67e-05	CcSEcCtD
Tinidazole—Dermatitis—Methotrexate—hematologic cancer	3.37e-05	9.66e-05	CcSEcCtD
Tinidazole—Headache—Methotrexate—hematologic cancer	3.35e-05	9.61e-05	CcSEcCtD
Tinidazole—Asthenia—Doxorubicin—hematologic cancer	3.33e-05	9.53e-05	CcSEcCtD
Tinidazole—Dizziness—Epirubicin—hematologic cancer	3.31e-05	9.49e-05	CcSEcCtD
Tinidazole—Pruritus—Doxorubicin—hematologic cancer	3.28e-05	9.4e-05	CcSEcCtD
Tinidazole—Vomiting—Epirubicin—hematologic cancer	3.19e-05	9.13e-05	CcSEcCtD
Tinidazole—Nausea—Methotrexate—hematologic cancer	3.18e-05	9.11e-05	CcSEcCtD
Tinidazole—Diarrhoea—Doxorubicin—hematologic cancer	3.17e-05	9.09e-05	CcSEcCtD
Tinidazole—Rash—Epirubicin—hematologic cancer	3.16e-05	9.05e-05	CcSEcCtD
Tinidazole—Dermatitis—Epirubicin—hematologic cancer	3.16e-05	9.04e-05	CcSEcCtD
Tinidazole—Headache—Epirubicin—hematologic cancer	3.14e-05	8.99e-05	CcSEcCtD
Tinidazole—Dizziness—Doxorubicin—hematologic cancer	3.07e-05	8.78e-05	CcSEcCtD
Tinidazole—Nausea—Epirubicin—hematologic cancer	2.98e-05	8.53e-05	CcSEcCtD
Tinidazole—Vomiting—Doxorubicin—hematologic cancer	2.95e-05	8.44e-05	CcSEcCtD
Tinidazole—Rash—Doxorubicin—hematologic cancer	2.92e-05	8.37e-05	CcSEcCtD
Tinidazole—Dermatitis—Doxorubicin—hematologic cancer	2.92e-05	8.37e-05	CcSEcCtD
Tinidazole—Headache—Doxorubicin—hematologic cancer	2.9e-05	8.32e-05	CcSEcCtD
Tinidazole—Nausea—Doxorubicin—hematologic cancer	2.75e-05	7.89e-05	CcSEcCtD
